BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact.
Source: Alpha Wolf Trading
In this Alpha Wolf Trading Interview, Tim speaks with CEO Dennis Calvert about several initiatives. BioLargo Inc. is positively positioned on several fronts that all have significant revenue opportunities moving forward.
This interview is a "deeper dive" into BioLargo's portfolio, monetization strategy, and commercial status!
No comments:
Post a Comment